Cannabis Sativa) Phytotoxicity, Biomass, and Seed Yield Brett A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Armenian Secret and Invented Languages and Argots
Armenian Secret and Invented Languages and Argots The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Russell, James R. Forthcoming. Armenian secret and invented languages and argots. Proceedings of the Institute of Linguistics of the Russian Academy of Sciences. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:9938150 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#OAP 1 ARMENIAN SECRET AND INVENTED LANGUAGES AND ARGOTS. By James R. Russell, Harvard University. Светлой памяти Карена Никитича Юзбашяна посвящается это исследование. CONTENTS: Preface 1. Secret languages and argots 2. Philosophical and hypothetical languages 3. The St. Petersburg Manuscript 4. The Argot of the Felt-Beaters 5. Appendices: 1. Description of St. Petersburg MS A 29 2. Glossary of the Ṙuštuni language 3. Glossary of the argot of the Felt-Beaters of Moks 4. Texts in the “Third Script” of MS A 29 List of Plates Bibliography PREFACE Much of the research for this article was undertaken in Armenia and Russia in June and July 2011 and was funded by a generous O’Neill grant through the Davis Center for Russian and Eurasian Studies at Harvard. For their eager assistance and boundless hospitality I am grateful to numerous friends and colleagues who made my visit pleasant and successful. For their generous assistance in Erevan and St. -
Cannabis in New Zealand Perceptions of Use, Users and Policy
Cannabis in New Zealand perceptions of use, users and policy Geoff Noller A thesis submitted for the degree of Doctor of Philosophy at the University of Otago, Christchurch Aotearoa, New Zealand November 5, 2008 ABSTRACT Introduction Despite humanity’s lengthy relationship with psychoactive substances, their consumption in contemporary societies is perceived as highly problematic. Cannabis, the most commonly imbibed illicit psychotropic, has come to embody these concerns. Medical and scientific research informs notions of use and user, with these being further constructed in the public realm by law, the media and policy against a backdrop of health deficits and other harms including risk taking, criminality and deviance. With many studies drawing on clinical populations, e.g. high intensity users or those in treatment, a pathologized view of the user predominates. Where general population studies incorporate user data, these typically concentrate on the epidemiology of use: frequency, intensity, duration, and symptoms of abuse and dependence. This, however, tells us little about the meaning of use for users or why use continues despite universal official disapprobation. A lack of studies incorporating user perspectives thus ensures the limited focus of much present research and a policy accent on supply reduction at the expense of harm minimisation and safe use education. Those choosing to continue use are stigmatised as deviant or dependant. This has the effect of further bolstering enforcement, a strategy showing little evidence of efficacy. The present study sought a comparison between this dominant discourse on cannabis use and the perspectives of users, with a range of exploratory hypotheses being identified. Method Eighty cannabis-using respondents participated in open-ended face-to-face interviews, of which seventy-six successfully completed a follow-up questionnaire. -
A Concise Dictionary of Middle English
A Concise Dictionary of Middle English A. L. Mayhew and Walter W. Skeat A Concise Dictionary of Middle English Table of Contents A Concise Dictionary of Middle English...........................................................................................................1 A. L. Mayhew and Walter W. Skeat........................................................................................................1 PREFACE................................................................................................................................................3 NOTE ON THE PHONOLOGY OF MIDDLE−ENGLISH...................................................................5 ABBREVIATIONS (LANGUAGES),..................................................................................................11 A CONCISE DICTIONARY OF MIDDLE−ENGLISH....................................................................................12 A.............................................................................................................................................................12 B.............................................................................................................................................................48 C.............................................................................................................................................................82 D...........................................................................................................................................................122 -
Marijuana Myths and Facts: the Truth Behind 10 Popular Misperceptions
MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY TABLE OF CONTENTS Introduction.............................................................................. 1 Myth #1: Marijuana is harmless .......................................... 3 Myth #2: Marijuana is not addictive ................................... 7 Myth #3: Marijuana is not as harmful to your health as tobacco............................................................. 9 Myth #4: Marijuana makes you mellow............................. 10 Myth #5: Marijuana is used to treat cancer and other diseases...................................................... 11 Myth #6: Marijuana is not as popular as MDMA (Ecstasy) or other drugs among teens today...................... 13 Myth #7: If I buy marijuana, I’m not hurting anyone else......................................................... 14 Myth #8: My kids won’t be exposed to marijuana ............. 17 Myth #9: There’s not much parents can do to stop their kids from experimenting with marijuana ........... 19 Myth #10: The government sends otherwise innocent people to prison for casual marijuana use......... 21 Conclusion .............................................................................. 23 Glossary.................................................................................. 25 References .............................................................................. -
Big Marijuana Claims Vs. the Science
Big Marijuana Claims Vs. The Science Big Marijuana Claims Scientific Facts Legalization is about one thing: making a small number of business people rich. If it were about ending the War on Drugs, recent law changes would be limited to decriminalization. Rather, a host of business interests are getting involved with the legal marijuana trade in Colorado and elsewhere. Legalization is about getting rid of They have set up private equity the “War on Drugs” firms and fundraising organizations to attract investors and promote items such as marijuana food items, oils, and other products.We also know these industries target the poor and disenfranchised[i] – and we can expect the marijuana industry to do the same in order to increase profits. Science has proven – and all major scientific and medical organizations agree – that marijuana is both addictive and harmful to the human brain, Marijuana is not addictive. especially when used as an adolescent. One in every six 16 year-olds (and one in every eleven adults) who try marijuana will become addicted to it.[ii] To your brain, addiction is addiction. Different addictions have different symptoms, but whether its food, sex, marijuana, or heroin – your brain knows it wants more of that feeling of pleasure. Marijuana MIGHT be Just as with alcohol and tobacco, psychologically addictive, but its most chronic marijuana users who addiction doesn’t produce physical attempt to stop “cold turkey” will symptoms. experience an array of withdrawal symptoms such as irritability, restlessness, anxiety, depression, insomnia, and/or cravings.[iii] This signals that marijuana can be addictive. Science has shown that 1 in 6 kids who ever try marijuana, according to the National Institutes of Health, will become addicted to the drug. -
SR-112 Science of Hemp: Production and Pest Management
University of Kentucky College of Agriculture, Food and Environment Agricultural Experiment Station SR-112 Science of Hemp: Production and Pest Management Science of Hemp: Production and Pest Management October 10 –11, 2019 Agricultural Kentucky Tobacco Research and Development Center | Veterinary Diagnostic Laboratory | Division of Regulatory Services | Research and Education Center Experiment Station Robinson Forest | Robinson Center for Appalachian Resource Sustainability | University of Kentucky Superfund Research Center | Equine Programs emp (Cannabis sativa with <0.3% THC content) is grown for fiber, grain, and cannabinoid extraction in Asia, Europe, and the Americas. Until recently, HCannabis sativa has been classified as a Schedule 1 controlled substance in the US. The Agricultural Act of 2014 (Farm Bill) allowed for reintroduction of industrial hemp under a pilot research program. Acreage increases and addition of state legislation resulted in over 78,000 acres of hemp grown in 23 states by the end of 2018. Hemp became a legal commodity under the 2018 Farm Bill, and by the end of 2019, over 500,000 licensed acres were documented across 45 states. Canada re-introduced the crop in 1998, and in 2018, almost 78,000 acres of hemp were licensed and planted. With this increase in acreage and the lack of modern scientific data, university and government agricultural specialists began to work on various components of production and a range of realized challenges. This new information, however, had either not been shared or was not readily accessible to the scientific community, especially early results and nonpublished data. The first annual meeting of the Science of Hemp: Production and Pest Management was held on October 10-11, 2019 at the University of Kentucky in Lexington, KY. -
EOF 2019 AGM Speeches
ASX ANNOUNCEMENT ASX: EOF ____________________________ 14 November 2019 Ecofibre Limited Annual General Meeting Speeches Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC – Nasdaq Intl Designation: EOFBF) Please find attached the Chairman and Managing Director addresses, and the accompanying slides, to be presented at Ecofibre Limited’s Annual General Meeting today in Sydney. Jonathan Brown Company Secretary 1 ASX ANNOUNCEMENT Investor Relations and Media please contact: Jonathan Brown, Company Secretary, Ecofibre Limited Level 12, 680 George Street, Sydney NSW 2000 [email protected] About Ecofibre Ecofibre is a provider of hemp products in the United States and Australia. In the United States, the Company produces nutraceutical products for human and pet consumption, as well as topical creams and salves. See www.anandahemp.com and www.anandaprofessional.com. In Australia, the Company produces 100% Australian grown and processed hemp food products including protein powders, de-hulled hemp seed and hemp oil. See www.anandafood.com. The Company is also developing innovative hemp-based products in textiles and composite materials in partnership with Thomas Jefferson University (TJU) in the United States. See www.hempblack.com. The Company owns or controls key parts of the value chain in each business, from breeding, growing and production to sales and marketing. Our value proposition to customers is built on strong brands and quality products. Authorisation This document is authorised to be given to the Australian Securities Exchange (ASX) by Eric Wang, Managing Director. 2 Ecofibre Limited Annual General Meeting Thursday, 14 November 2019 Chairman and Managing Director’s Address Chairman’s Address Ecofibre listed on the ASX on 29 March 2019 at a price of $1.00 per share and a total value of just over $300m. -
Medical Marijuana: Clinical Concepts Jennifer Kapur, Pharm.D
11/3/2015 MEDICAL MARIJUANA: CLINICAL CONCEPTS JENNIFER KAPUR, PHARM.D. NOVEMBER 21, 2015 OBJECTIVES Compare and contrast federal law and state laws regarding marijuana List different dosage forms of medical marijuana Discuss the pharmacologic effects of marijuana Describe the risks and benefits of medical marijuana use Summarize the role of the pharmacist in the care of patients using medical marijuana CASE: MARILYN 68yo female with breast cancer metastatic to the lungs and thoracic and lumbar spine Meds: Doxorubicin Ondansetron and prochlorperazine Acetaminophen 1000mg q8h Oxycodone 5-10mg QHS prn Complains of very low energy, minimal appetite, substantial pain in spine She asks you about the possibility of using marijuana to help with nausea, pain and fatigue What advice will you offer regarding the use of marijuana to alleviate her current symptoms? Do you believe the the overall medicinal benefits outweigh the risks? NEJM. 2013;368(9)866-868. 1 11/3/2015 HISTORY OF MEDICAL MARIJUANA William Brooke O’Shaughnessy Introduced marijuana to Western medicine in the mid-1800s From www.en.Wikipedia.org HISTORY OF MEDICAL MARIJUANA 1851: Marijuana added to US Pharmacopeia 1942: Marijuana removed from US Pharmacopeia 1970: Marijuana classified as Schedule 1 under Controlled Substances Act 1996: California becomes first state to legalize medical marijuana 1998: Alaska, Oregon and Washington legalize medical marijuana Currently 23 states and the District of Columbia have legalized medical marijuana 2 11/3/2015 MEDICAL MARIJUANA IN WASHINGTON STATE HEALTHCARE PROVIDERS WHO MAY RECOMMEND MEDICAL MARIJUANA* Medical doctors (MDs) Physicians assistants (PAs) Osteopathic physicians (DOs) Osteopathic physician assistants (OAs) Naturopathic physicians (NDs) Advanced registered nurse practitioners (ARNPs) *Must be licensed in Washington state Healthcare providers must NOT PRESCRIBE marijuana. -
Cannabis Pathogens XI: Septoria Spp
©Verlag Ferdinand Berger & Söhne Ges.m.b.H., Horn, Austria, download unter www.biologiezentrum.at Cannabis pathogens XI: Septoria spp. on Cannabis sativa, sensu stricto John M. McPartland Vermont Alternative Medicine/AMRITA, Middlebury, VT 05753, U.S.A. McPartland, J. M. (1995). Cannabis pathogens XI: Septoria spp. on Cannabis sativa, sensu stricto. - Sydowia 47 (1): 44-53. Two species of Septoria on C. sativa are described and contrasted. 5. cannabina Westendorp and Spilosphaeria cannabis Rabenhorst become synonyms of S. cannabis (Lasch) Saccardo. S. cannabina Peck is illegitimate, S. neocannabina nom. nov. takes its place; Septoria cannabis var. microspora Briosi & Cavara becomes a synonym therein. S. graminum Desmazieres is not considered a Cannabis pathogen; 'Cylindrosporium sp.' on hemp is a specimen of S. neocannabina, Rhabdospora cannabina Fautrey is discussed. Keywords: Cannabis sativa, Cylindrosporium, exsiccata, Septoria, taxonomy. The genus Septoria Saccardo is quite unwieldy, containing about 2000 taxa. Sutton (1980) notes some workers have subdivided and studied the genus by geographical area. Grouping Septoria spp. by their host range is a more natural way of studying the genus in surmountable subunits. Six previous papers have revised Septoria spp. based on host studies (Punithalingham & Wheeler, 1965; Constantinescu, 1984; Sutton & Pascoe, 1987; Farr, 1991, 1992a, 1992b). Their results suggest Septoria host ranges are limited, and support the continued study of Septoria by host groupings. These compilations and comparisons are especially useful when cultures are lacking. Several species of Septoria reportedly cause yellow leaf spot on Cannabis (McPartland, 1991). Together they make this disease nearly ubiquitous; it occurs on every continent save Antarctica. The U.S. -
Legal Questions About CBD and Marijuana in Schools Published Online in TASB School Law Esource
Legal Questions About CBD and Marijuana in Schools Published online in TASB School Law eSource The law involving marijuana is in flux. A majority of states have legalized medical marijuana to some extent, including the District of Columbia and eleven states that allow for recreational use. Federal laws also address marijuana. As new approaches continue to be tested in the ‘laboratories of democracy,’ the marketplace has responded with cannabis-related products such as cannabidiol (CBD), which can be purchased in any jurisdiction thanks to the Internet. School officials may be wondering how these new products and legal developments impact Texas public schools. What is CBD? CBD, or cannabidiol, is one of many naturally occurring chemical compounds of Cannabis sativa L., the plant from which both marijuana and hemp are derived. Tetrahydrocannabinol, or THC, is another compound of the cannabis plant. The primary difference between hemp and marijuana is the amount of THC, which is the main component of marijuana that creates a “high” sensation. Both hemp and marijuana contain CBD, which is non-intoxicating. CBD has been shown to be effective in treating some forms of epilepsy. Preliminary research has also suggested that CBD may be used to treat other health conditions, including anxiety, insomnia, and chronic pain.1 Unlike whole-plant marijuana, which is usually smoked or vaporized, CBD is commonly consumed as an oil extract or a pre-mixed additive in food or beverages. How do Texas and federal laws treat CBD and medical marijuana? Both Texas and federal laws have decriminalized CBD that is extracted from hemp. -
Cannabis Britannica: the Rise and Demise of a Victorian Wonder-Drug Transcript
Cannabis Britannica: The rise and demise of a Victorian wonder-drug Transcript Date: Monday, 18 March 2013 - 1:00PM Location: Museum of London 18 March 2013 Cannabis Britannica: The Rise and Demise of the Victorian Wonder-drug Professor James Mills There was little awareness of the medicinal and intoxicating properties of cannabis in Britain before the nineteenth-century. Varieties of the cannabis plant had long been cultivated in the country, but they were grown because the plant was a useful source of fibre for sacking, ropes and rigging. The climate in the UK and the varieties domesticated here meant that little psychoactive material was present in the plant. Medical dictionaries and botanical enyclopaedia of the eighteenth-century did include the occasional reference to the varieties of the plant which produced psychoactive substances, but these entries suggest that this knowledge was being recycled from earlier sources rather than from actual experience of these plants of preparations of them. It was only when British doctors and scientists began to circulate more regularly around the expanding empire of the early 1800s that they began to encounter societies where cannabis was cultivated for its medicinal and intoxicating potential. One of the earliest of these British doctors was Whitelaw Ainslie. He published the following account of ‘Ganjah’ in 1813. Ganjah (Tamil, Duk and Malay), Kanub (Arab), Hemp Cannabis Sativa, Vijya, Sanjica (Sanskrit). Ganjah is the Tamool name of the plant from which Bangie and Majum are prepared. The leaves are frequently added to tobacco and smoaked [sic] to increase its intoxicating power; they are also sometimes, given in cases of Diarrhoea and in conjunction with Turmeric, Onions and warm Ginglie oil, are made into an application for pinful, swelled and protruded Piles. -
Annual Report 2020
ANNUAL REPORT 2020 ANNUAL ANNUAL REPORT REPORT 2020 2020 CONTENTS FINANCIAL HIGHLIGHTS Financial Operating + 1 Highlights 14 Financial Review Financial Financial 1 Highlights 30 Report 2019 Chairman’s Financial 4 Letter 30 Report 2020 Chairman’s Independent 4 Letter 77 Auditor’s Report Managing Independent 8 Director’s 85 Auditor’s Letter Report Managing Director’s Shareholders 6 Letter 81 Information Shareholders’ Revenue US independent pharmacies 90 Information up 519% from $5.7m to up 510% from 525 to Operating + Corporate 10 Financial Review 85 Directory Corporate $35.6m 3,200 93 Directory About Ecofibre NPAT Channel mix Ecofibre is a provider of hemp products in the United up 170% from $8.6m loss to Branded channel sales States and Australia. In the United States, the Ananda Health business is the #1 + $6.0m 84% provider of hemp-derived CBD for retail pharmacies. The Company produces nutraceutical products for human and pet consumption, as well as topical creams and salves. See www.anandahemp.com and www.anandaprofessional.com. The Company also supplies its leading Ananda Hemp CBD Fully diluted EPS Gross Margin products to Australians via the SAS B program. up 158% from 3.7 cps loss to for H2 FY2019 In Australia, the Company produces 100% Australian grown and processed hemp food products including protein 2.2 CPS 77% powders, de-hulled hemp seed and hemp oil. See + www.anandafood.com. The Company is also developing innovative hemp-based products in textiles and composite materials in the United Net Assets EBITDA margin States. See www.hempblack.com. up from $1.6m to for H2 FY2019 The Company owns or controls key parts of the value chain in each business, from breeding, growing and production to $ sales and marketing.